Ticker name:INSMINSMED Inc

Country: US-Sector: Healthcare, Industry: Biotechnology

terraforming in: 2025

Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.

Market Cap 27B

Last close 123.98$

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA131B516.34$
2REGNREGENERON PHARMACEUTICALS, INC.81B789.45$
3MRNAModerna, Inc.63B158.07$
4RVMDRevolution Medicines, Inc.42B196.94$
5ALNYALNYLAM PHARMACEUTICALS, INC.33B245.51$
6ROIVRoivant Sciences Ltd.29B39.98$
7INSMINSMED Inc27B123.98$
8INCYINCYTE CORP26B127.62$
9UTHRUNITED THERAPEUTICS Corp21B497.27$
10JAZZJazz Pharmaceuticals plc16B243.84$
11ASNDAscendis Pharma A/S16B239.04$
12NBIXNEUROCRINE BIOSCIENCES INC15B151.83$
13EXELEXELIXIS, INC.14B58.49$
14SMMTSummit Therapeutics Inc.14B17.72$
15BBIOBridgeBio Pharma, Inc.13B67.31$
16BMRNBIOMARIN PHARMACEUTICAL INC13B65.08$
17HALOHALOZYME THERAPEUTICS, INC.12B109.68$
18CORTCORCEPT THERAPEUTICS INC12B114.86$
19MDGLMADRIGAL PHARMACEUTICALS, INC.12B534.4$
20TECHBIO-TECHNE Corp11B72.41$